Tech Company Financing Transactions
ReviR Therapeutics Funding Round
California Institute for Regenerative Medicine invested in a $4.6 million capital raise for ReviR Therapeutics. The round was announced on 11/20/2025.
Transaction Overview
Company Name
Announced On
11/20/2025
Transaction Type
Debt
Amount
$4,600,000
Round
Undisclosed
Proceeds Purpose
This funding will further support the advancement of ReviR Therapeutics' HTT-PMS1 genetic medicine program, whereby a small molecule selectively reduces the mRNA of two genes implicated in both the cause and progression of Huntington's disease (HD).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
150 North Hill Drive
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease. Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered "undruggable"
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peng Yue
Chief Scientific Officer
Paul August
Vice President
Yang Liu
Vice President
Sridhar Narayan
VP - Bus. Development
Sarah Burnett
VP - R & D
Steve Lianoglou
Browse more venture capital transactions:
Prev: 11/20/2025: Kraken venture capital transaction
Next: 11/21/2025: XNRGY Climate Systems venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs